Literature DB >> 25488988

CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Kristina S Burrack1, Stephanie A Montgomery2, Dirk Homann3, Thomas E Morrison4.   

Abstract

Ross River virus (RRV), chikungunya virus, and related alphaviruses cause debilitating polyarthralgia and myalgia. Mouse models of RRV and chikungunya virus have demonstrated a role for the adaptive immune response in the control of these infections. However, questions remain regarding the role for T cells in viral control, including the magnitude, location, and dynamics of CD8(+) T cell responses. To address these questions, we generated a recombinant RRV expressing the H-2(b)-restricted glycoprotein 33 (gp33) determinant derived from the glycoprotein of lymphocytic choriomeningitis virus. Using tetramers, we tracked gp33-specific CD8(+) T cells during RRV-lymphocytic choriomeningitis virus infection. We found that acute RRV infection induces activation of CD8(+) T cell responses in lymphoid and musculoskeletal tissues that peak from 10-14 d postinoculation, suggesting that CD8(+) T cells contribute to control of acute RRV infection. Mice genetically deficient for CD8(+) T cells or wild-type mice depleted of CD8(+) T cells had elevated RRV loads in skeletal muscle tissue, but not joint-associated tissues, at 14 d postinoculation, suggesting that the ability of CD8(+) T cells to control RRV infection is tissue dependent. Finally, adoptively transferred T cells were capable of reducing RRV loads in skeletal muscle tissue of Rag1(-/-) mice, indicating that T cells can contribute to the control of RRV infection in the absence of B cells and Ab. Collectively, these data demonstrate a role for T cells in the control of RRV infection and suggest that the antiviral capacity of T cells is controlled in a tissue-specific manner.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25488988      PMCID: PMC4282972          DOI: 10.4049/jimmunol.1401833

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

1.  Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Authors:  Haiyan Chu; Subash C Das; Jeremy F Fuchs; M Suresh; Scott C Weaver; Dan T Stinchcomb; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2013-05-29       Impact factor: 3.641

2.  Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe.

Authors:  W Van Bortel; F Dorleans; J Rosine; A Blateau; D Rousset; S Matheus; I Leparc-Goffart; O Flusin; Cm Prat; R Cesaire; F Najioullah; V Ardillon; E Balleydier; L Carvalho; A Lemaître; H Noel; V Servas; C Six; M Zurbaran; L Leon; A Guinard; J van den Kerkhof; M Henry; E Fanoy; M Braks; J Reimerink; C Swaan; R Georges; L Brooks; J Freedman; B Sudre; H Zeller
Journal:  Euro Surveill       Date:  2014-04-03

3.  Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice.

Authors:  B A Lidbury; C Simeonovic; G E Maxwell; I D Marshall; A J Hapel
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

4.  An essential role of antibodies in the control of Chikungunya virus infection.

Authors:  Fok-Moon Lum; Teck-Hui Teo; Wendy W L Lee; Yiu-Wing Kam; Laurent Rénia; Lisa F P Ng
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

5.  Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.

Authors:  Vesselin T Tomov; Lisa C Osborne; Douglas V Dolfi; Gregory F Sonnenberg; Laurel A Monticelli; Kathleen Mansfield; Herbert W Virgin; David Artis; E John Wherry
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

6.  A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice.

Authors:  Teck-Hui Teo; Fok-Moon Lum; Carla Claser; Valeria Lulla; Aleksei Lulla; Andres Merits; Laurent Rénia; Lisa F P Ng
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

7.  Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection.

Authors:  Kristina A Stoermer Burrack; David W Hawman; Henri J Jupille; Lauren Oko; Marissa Minor; Katherine D Shives; Bronwyn M Gunn; Kristin M Long; Thomas E Morrison
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

8.  Use of human monoclonal antibodies to treat Chikungunya virus infection.

Authors:  Jan Fric; Sébastien Bertin-Maghit; Cheng-I Wang; Alessandra Nardin; Lucile Warter
Journal:  J Infect Dis       Date:  2012-11-02       Impact factor: 5.226

9.  A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts.

Authors:  Henri J Jupille; Melisa Medina-Rivera; David W Hawman; Lauren Oko; Thomas E Morrison
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

10.  Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.

Authors:  Pankaj Pal; Kimberly A Dowd; James D Brien; Melissa A Edeling; Sergey Gorlatov; Syd Johnson; Iris Lee; Wataru Akahata; Gary J Nabel; Mareike K S Richter; Jolanda M Smit; Daved H Fremont; Theodore C Pierson; Mark T Heise; Michael S Diamond
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

View more
  17 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Chikungunya Virus Evades Antiviral CD8+ T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.

Authors:  Bennett J Davenport; Christopher Bullock; Mary K McCarthy; David W Hawman; Kenneth M Murphy; Ross M Kedl; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment.

Authors:  Mary K McCarthy; Bennett J Davenport; Glennys V Reynoso; Erin D Lucas; Nicholas A May; Susan A Elmore; Beth A Tamburini; Heather D Hickman; Thomas E Morrison
Journal:  JCI Insight       Date:  2018-07-12

4.  An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses.

Authors:  Ningning Ge; Jin Sun; Zhihua Liu; Jiayi Shu; Huimin Yan; Zhihua Kou; Yu Wei; Xia Jin
Journal:  Virol Sin       Date:  2022-01-28       Impact factor: 6.947

5.  Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells.

Authors:  Kristina S Burrack; Jeslin J L Tan; Mary K McCarthy; Zhisheng Her; Jennifer N Berger; Lisa F P Ng; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2015-10-05       Impact factor: 6.823

6.  Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum.

Authors:  Wen-Tao Yang; Shao-Hua Shi; Gui-Lian Yang; Yan-Long Jiang; Liang Zhao; Yu Li; Chun-Feng Wang
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

7.  RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Authors:  Jane A C Wilson; Natalie A Prow; Wayne A Schroder; Jonathan J Ellis; Helen E Cumming; Linden J Gearing; Yee Suan Poo; Adam Taylor; Paul J Hertzog; Francesca Di Giallonardo; Linda Hueston; Roger Le Grand; Bing Tang; Thuy T Le; Joy Gardner; Suresh Mahalingam; Pierre Roques; Phillip I Bird; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-02-16       Impact factor: 6.823

Review 8.  Chikungunya and diabetes, what do we know?

Authors:  Francisca Kalline de Almeida Barreto; Renan Magalhães Montenegro; Virginia Oliveira Fernandes; Rhaquel Oliveira; Lívia Aline de Araújo Batista; Akhtar Hussain; Luciano Pamplona de Góes Cavalcanti
Journal:  Diabetol Metab Syndr       Date:  2018-04-13       Impact factor: 3.320

Review 9.  Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease.

Authors:  Helen Mostafavi; Eranga Abeyratne; Ali Zaid; Adam Taylor
Journal:  Viruses       Date:  2019-03-22       Impact factor: 5.048

Review 10.  Arboviruses and Muscle Disorders: From Disease to Cell Biology.

Authors:  Claudia Filippone; Vincent Legros; Patricia Jeannin; Valérie Choumet; Gillian Butler-Browne; Jim Zoladek; Vincent Mouly; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2020-06-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.